
Veradigm Inc. (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on

<p xmlns="http://www.w3.org/1999/xhtml">
Veradigm Inc.<sup xmlns="http://www.w3.org/1999/xhtml"> </sup>(OTC:<a class="ticker" href="https://www.benzinga.com/quote/MDRX">MDRX</a>), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Mr. Greyenbuhl is a seasoned operator and finance executive with more than 25 years of experience across both global public and private companies. He brings a strong track record as a general manager and operator, having served as general manager of businesses of Automatic Data Processing, Inc. ("ADP") on two occasions and having led large-scale financial systems transformations. He most recently served as Chief Financial Officer for Ministry Brands, LLC, a SaaS-based technology company, where he has led all aspects of its finance organization since November 2022.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Our ‘Reset, Recover, Reignite' plan is fully launched. Our work to get current and stay current on our SEC filing is progressing," said Donald Trigg, Chief Executive Officer of Veradigm. "With Christian's arrival, the team required to drive our strategic reset, recover our market leadership with independent physician practices, and reignite profitable growth will be largely in place."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"I am honored to join the Veradigm team at such a pivotal moment," said Mr. Greyenbuhl. "Veradigm has a unique opportunity to leverage its strong market position, differentiated capabilities, and powerful data assets to deliver more actionable insights across the healthcare ecosystem. I look forward to leveraging my accounting and operational strengths to work to ensure that the Company becomes current with its filing obligations and reignites profitable growth."

</p><p xmlns="http://www.w3.org/1999/xhtml">
Prior to Ministry Brands, Mr. Greyenbuhl served as SVP Corporate Finance and Investor Relations at Xplor Technologies LLC, a global SaaS-based technology company. Prior to Xplor Technologies, Mr. Greyenbuhl spent over 10 years at ADP in increasingly senior roles following 11 years at PricewaterhouseCoopers working with a variety of public and private clients across a broad range of industries. Mr. Greyenbuhl is both a Chartered Accountant with the Institute of Chartered Accountants of Scotland as well as a Certified Public Accountant (inactive) and holds a Bachelor of Arts degree in Accountancy with Business Law from the University of Stirling in Scotland, UK.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Mr. Greyenbuhl succeeds Lee Westerfield, the Company's Interim Chief Financial Officer. Following Mr. Greyenbuhl's appointment, Mr. Westerfield will serve the Company in a consulting role to help ensure a smooth transition of responsibilities.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"On behalf of myself and the Board of Directors, I want to thank Lee for his tireless service during a time of leadership transition at Veradigm," said Mr. Trigg. "Lee has led our efforts to ‘get current and stay current' on our SEC filings, and the financing that strengthened our liquidity. I look forward to continuing to collaborate with him as we advance key filing milestones."

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Veradigm&#xAE;</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.

</p><p xmlns="http://www.w3.org/1999/xhtml">
&#xA9; 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Disclaimer and Forward-Looking Statement Information</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, the Company's strategic initiatives under its new leadership and the timing of Mr. Greyenbuhl's appointment as Chief Financial Officer of Veradigm Inc. (the "Company"). These forward-looking statements are based on the current beliefs and expectations of the Company's management with respect to future events, only speak as of the date that they are made, and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "continue," "can," "may," "look forward," "aims," "hopes," and "seeks" and similar terms, although not all forward-looking statements contain such words or expressions. Actual results could differ significantly from those set forth in the forward-looking statements.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, risks relating to the Company's common stock not trading on a national securities exchange and deregistration from Section 12(b) of the Securities Exchange Act of 1934, as amended; a further material delay in the Company's financial reporting; an inability of the Company to timely prepare its delinquent financial statements; unanticipated factors or factors that the Company currently believes will not cause further delay; the Company's remediation efforts and preparation of financial statements or other factors that could cause additional delay or adjustments; the possibility that ongoing remediation work or the audit of the Company's financial statements for the fiscal years ended December 31, 2023, 2024, or 2025 may identify additional errors and material weaknesses or other deficiencies in the Company's accounting practices; the likelihood that the control deficiencies identified or that may be identified in the future will result in additional material weaknesses in the Company's internal control over financial reporting; the Company's ability to hire qualified individuals to serve in senior leadership roles on a permanent basis; and other factors contained in the "Risk Factors" section and elsewhere in the 2022 Form 10-K and the Company's other filings with the SEC from time to time. The Company does not undertake to update any forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes over time, except as required by law.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260406026774r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260406026774/en/" rel="nofollow">https://www.businesswire.com/news/home/20260406026774/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">For more information contact:</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Investors: 
</span><br xmlns="http://www.w3.org/1999/xhtml"></br>Steven Halper
<br xmlns="http://www.w3.org/1999/xhtml"></br>312-506-1237
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:steve.halper@veradigm.com" shape="rect">steven.halper@veradigm.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Media: 
</span><br xmlns="http://www.w3.org/1999/xhtml"></br>Amanda Cohen
<br xmlns="http://www.w3.org/1999/xhtml"></br>732-567-7607
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:amanda.cohen@veradigm.com" shape="rect">amanda.cohen@veradigm.com</a>

</p>

MDRX

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

Veradigm Appoints New CFO to Drive Strategic Recovery Plans

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Veradigm Inc. (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Veradigm has appointed Christian Greyenbuhl as CFO, with a focus on renewing financial health and compliance. His extensive experience positions the company for a strategic reset, which may enhance market leadership and drive profitable growth in the coming years.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Veradigm appoints Christian Greyenbuhl as CFO effective May 2026.</li><li>Greyenbuhl has 25 years of experience in finance and operations.</li><li>CEO emphasizes strategic plan to recover market leadership and growth.</li><li>Former CFO Lee Westerfield will assist during the transition.</li><li>Company aims to reinvigorate its financial health and SEC compliance.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Automatic Data Processing, Inc. (ADP)</strong>: Greyenbuhl’s previous roles might enhance Veradigm&#039;s operational insights.</li><li><strong>Ministry Brands, LLC</strong>: Greyenbuhl&#039;s SaaS experience may influence product innovation at Veradigm.</li><li><strong>Xplor Technologies LLC</strong>: Leadership in technology aligns with Veradigm&#039;s focus on AI-driven solutions.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This news fits under &#039;Corporate Developments&#039; as it involves a significant leadership change aimed at revitalizing the company&#039;s strategic direction.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Appointment of experienced CFO may boost investor confidence and stabilize stock.</li><li>Successful execution of strategic reset could attract more healthcare partnerships.</li><li>Progress on SEC filing compliance essential to prevent further delays.</li><li>Potential increase in revenue from optimized clinical and revenue cycle solutions.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Christian Greyenbuhl appointed CFO effective May 2026.</li><li>Over 25 years of experience in finance and management.</li><li>Company&#039;s &#039;Reset, Recover, Reignite&#039; plan is underway.</li><li>Former CFO Lee Westerfield will serve as consultant post-transition.</li><li>Veradigm provides solutions for over 20,000 provider practices.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>MDRX could see increased investor confidence in the short term due to new leadership aimed at stabilizing operations.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
Veradigm Inc.<sup xmlns="http://www.w3.org/1999/xhtml"> </sup>(OTC:<a class="ticker" href="https://www.benzinga.com/quote/MDRX">MDRX</a>), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Mr. Greyenbuhl is a seasoned operator and finance executive with more than 25 years of experience across both global public and private companies. He brings a strong track record as a general manager and operator, having served as general manager of businesses of Automatic Data Processing, Inc. ("ADP") on two occasions and having led large-scale financial systems transformations. He most recently served as Chief Financial Officer for Ministry Brands, LLC, a SaaS-based technology company, where he has led all aspects of its finance organization since November 2022.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"Our ‘Reset, Recover, Reignite' plan is fully launched. Our work to get current and stay current on our SEC filing is progressing," said Donald Trigg, Chief Executive Officer of Veradigm. "With Christian's arrival, the team required to drive our strategic reset, recover our market leadership with independent physician practices, and reignite profitable growth will be largely in place."

</p><p xmlns="http://www.w3.org/1999/xhtml">
"I am honored to join the Veradigm team at such a pivotal moment," said Mr. Greyenbuhl. "Veradigm has a unique opportunity to leverage its strong market position, differentiated capabilities, and powerful data assets to deliver more actionable insights across the healthcare ecosystem. I look forward to leveraging my accounting and operational strengths to work to ensure that the Company becomes current with its filing obligations and reignites profitable growth."

</p><p xmlns="http://www.w3.org/1999/xhtml">
Prior to Ministry Brands, Mr. Greyenbuhl served as SVP Corporate Finance and Investor Relations at Xplor Technologies LLC, a global SaaS-based technology company. Prior to Xplor Technologies, Mr. Greyenbuhl spent over 10 years at ADP in increasingly senior roles following 11 years at PricewaterhouseCoopers working with a variety of public and private clients across a broad range of industries. Mr. Greyenbuhl is both a Chartered Accountant with the Institute of Chartered Accountants of Scotland as well as a Certified Public Accountant (inactive) and holds a Bachelor of Arts degree in Accountancy with Business Law from the University of Stirling in Scotland, UK.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Mr. Greyenbuhl succeeds Lee Westerfield, the Company's Interim Chief Financial Officer. Following Mr. Greyenbuhl's appointment, Mr. Westerfield will serve the Company in a consulting role to help ensure a smooth transition of responsibilities.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"On behalf of myself and the Board of Directors, I want to thank Lee for his tireless service during a time of leadership transition at Veradigm," said Mr. Trigg. "Lee has led our efforts to ‘get current and stay current' on our SEC filings, and the financing that strengthened our liquidity. I look forward to continuing to collaborate with him as we advance key filing milestones."

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">About Veradigm&#xAE;</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.

</p><p xmlns="http://www.w3.org/1999/xhtml">
&#xA9; 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Disclaimer and Forward-Looking Statement Information</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, the Company's strategic initiatives under its new leadership and the timing of Mr. Greyenbuhl's appointment as Chief Financial Officer of Veradigm Inc. (the "Company"). These forward-looking statements are based on the current beliefs and expectations of the Company's management with respect to future events, only speak as of the date that they are made, and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "continue," "can," "may," "look forward," "aims," "hopes," and "seeks" and similar terms, although not all forward-looking statements contain such words or expressions. Actual results could differ significantly from those set forth in the forward-looking statements.

</p><p xmlns="http://www.w3.org/1999/xhtml">
Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, risks relating to the Company's common stock not trading on a national securities exchange and deregistration from Section 12(b) of the Securities Exchange Act of 1934, as amended; a further material delay in the Company's financial reporting; an inability of the Company to timely prepare its delinquent financial statements; unanticipated factors or factors that the Company currently believes will not cause further delay; the Company's remediation efforts and preparation of financial statements or other factors that could cause additional delay or adjustments; the possibility that ongoing remediation work or the audit of the Company's financial statements for the fiscal years ended December 31, 2023, 2024, or 2025 may identify additional errors and material weaknesses or other deficiencies in the Company's accounting practices; the likelihood that the control deficiencies identified or that may be identified in the future will result in additional material weaknesses in the Company's internal control over financial reporting; the Company's ability to hire qualified individuals to serve in senior leadership roles on a permanent basis; and other factors contained in the "Risk Factors" section and elsewhere in the 2022 Form 10-K and the Company's other filings with the SEC from time to time. The Company does not undertake to update any forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes over time, except as required by law.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260406026774r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260406026774/en/" rel="nofollow">https://www.businesswire.com/news/home/20260406026774/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">For more information contact:</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Investors: 
</span><br xmlns="http://www.w3.org/1999/xhtml"></br>Steven Halper
<br xmlns="http://www.w3.org/1999/xhtml"></br>312-506-1237
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:steve.halper@veradigm.com" shape="rect">steven.halper@veradigm.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
<span xmlns="http://www.w3.org/1999/xhtml" class="bwuline">Media: 
</span><br xmlns="http://www.w3.org/1999/xhtml"></br>Amanda Cohen
<br xmlns="http://www.w3.org/1999/xhtml"></br>732-567-7607
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:amanda.cohen@veradigm.com" shape="rect">amanda.cohen@veradigm.com</a>

</p>

Veradigm has appointed Christian Greyenbuhl as CFO, with a focus on renewing financial health and compliance. His extensive experience positions the company for a strategic reset, which may enhance market leadership and drive profitable growth in the coming years.

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News